---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-110653"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2023-10-23T23:59:59+00:00"
generated_at: "2026-06-09T16:38:35.353904+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech secures $10M revolving credit facility from CEO; $3.5M available, matures March 2026

## Summary
- Revolving credit facility of up to $10M from Pardeep Nijhawan Medicine Professional Corp., controlled by CEO.
- Initial credit limit of $3.5M; facility matures March 31, 2026 unless terminated by 90 days' notice.
- Interest at CIBC US Base Rate plus 3% per annum; monthly standby fee of 1.5% on unused portion.
- Repayment due within 5 business days of receiving funds from Canada's Strategic Innovation Fund (SIF).
- Borrowing base tied to eligible SIF grant and license fee receivables; 85% advance rate.

## SEC filing metadata
- accession: 0001104659-23-110653
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2023-10-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000110465923110653/0001104659-23-110653-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000110465923110653/tm2328896d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-110653
- JSON: https://secwatch.observer/filing/0001104659-23-110653.json
- Plain text: https://secwatch.observer/filing/0001104659-23-110653.txt

## Key facts
- Material Agreements
  Edesa Biotech, Inc. entered into Credit Agreement with Pardeep Nijhawan Medicine Professional Corporation valued at $10 million (effective 2023-10-20).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Pardeep Nijhawan Medicine Professional Corporation
  - Value: $10 million
  - Effective: 2023-10-20
  source text: Effective October 20, 2023, the Company entered into a Credit Agreement (the “ Credit Agreement ”) with Pardeep Nijhawan Medicine Professional Corporation (the “ Lender ”), an entity controlled by Dr. Nijhawan, providing for an unsecured revolving credit facility (the “ Facility ”) in the principal amount of up to $10 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1540159/000110465923110653/0001104659-23-110653-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.